<DOC>
	<DOCNO>NCT01470677</DOCNO>
	<brief_summary>This randomize trial 140 woman endometrial cervical cancer undergo removal lymph tissue ( lymphadenectomy ) . The application 4 tachosil fibrin patch pelvic side wall tissue removal test intervention tissue removal . The primary endpoint evaluate incidence symptomatic pelvic lymphoceles define CTCAE 4.03 grade &gt; 2 within 4 week surgery woman undergo open laparoscopic pelvic lymphadenectomy cervical endometrial cancer without application Tachosil® surgery . The study 's hypothesis application tachosil fibrin patch significantly reduce rate symptomatic lymph cyst .</brief_summary>
	<brief_title>Tachosil Prevention Symptomatic Lymph Cysts</brief_title>
	<detailed_description>1 . Background Women gynecologic malignancy cervical endometrial cancer routinely undergo pelvic lymphadenectomy base tumor characteristic assess prior surgery . Pelvic lymphadenectomy may perform open surgery laparoscopy ( 1-4 ) . Postoperative complication pelvic lymphadenectomy include local abscess , bleeding , lymphocele , chronic lymphedema low extremity , incidence 1 2 % ( 2,3 ) . In present trial , focus pelvic lymphoceles , one common complication pelvic lymphadenectomy . Simonato et al . describe rate 19/30 ( 63 % ) sonographically detect lymphoceles men undergo pelvic extraperitoneal lymphadenectomy prostate cancer ( 4 ) . In trial , 4/19 men lymphoceles symptomatic required medical intervention . In woman cervical cancer , asymptomatic lymphoceles detect ultrasound note 11 % woman pelvic lymphadenectomy ( 1,3,5 ) . In 2 % woman , clinical symptom require therapeutic intervention ( 5 ) . Tachosil® fibrin-collagen coat patch heas license 2004 2007 Europe surgical use human support surgical hemostatic intervention . The efficacy safety Tachosil® demonstrate liver resection , pulmonary lobectomy , kidney tumor resection trial ( 6-8 ) . In men , woman , demonstrated application collagen-fibrin patch lymphadenectomy surgery site may prevent significant proportion lymphoceles . In randomized trial , Simonato et al . find pelvic application two Tachosil® patch obturator fossa femoral canal sufficient significantly reduce rate sonographically detect lymphoceles within 4 week surgery 19/30 5/30 case ( p=0.001 ) well mean drainage volume 190 64 ml . Percutaneous puncture symptomatic lymphocele necessary 1/30 individual intervention group compare 4/30 individual control group . ( 4 ) . In woman gynecologic malignancy single center randomize controlled trial find , Tachosil® seem effective reduce rate lymphoceles pelvic lymphadenectomy ( 5 ) . 7/30 ( 23.3 % ) woman treatment group compare 9/28 ( 57.7 % ) woman control group develop asymptomatic lymphoceles ( p &lt; 0.05 ) ( 5 ) . No significant difference two group observe development symptomatic lymphoceles rate intervention ( 5 ) . This may attributable small sample size study . As symptomatic lymphoceles relevant patient , seem clinically important evaluate impact Tachosil® rate symptomatic lymphoceles pelvic lymphadenectomy . Symptomatic lymphoceles define CTCA 4.03 grade system lymphoceles grade &gt; 2 . This include lymphoceles need medical intervention . Thus definition comprises , lymphoceles presence localize pelvic pain , pelvic abscess , fever , and/or leg edema presence sonographically verify pelvic lymphocele . In summary , data available literature demonstrate pelvic lymphocles occur 11 63 % individual undergoing pelvic lymphadenectomy . Symptomatic lymphoceles seem occur 32 % patient undergoing pelvic lymphadenectomy . Intraoperative application collagen-fibrin patch may reduce number lymphoceles , mean drainage volume , necessity medical intervention percutaneous puncture . Therefore , intend perform multi center randomize clinical trial assess efficacy collagen-fibrin patch prevent symptomatic lymphoceles woman undergo pelvic lymphadenectomy gynecologic malignancy , ie cervical endometrial cancer . We hypothesize , base data Simonato et al . Tinelli et al. , application collagen-fibrin patch ( Tachosil® ) reduce number symptomatic pelvic lymphoceles least 66 % . Primary outcome variable : 2.1 . To evaluate incidence symptomatic pelvic lymphoceles define CTCAE 4.03 grade &gt; 2 within 4 week surgery woman undergo open laparoscopic pelvic lymphadenectomy cervical endometrial cancer without application Tachosil® surgery . Secondary outcome variable : 2.2 . To evaluate incidence sonographically detect pelvic lymphoceles least 2cm large diameter 4 week surgery woman undergo open laparoscopic pelvic lymphadenectomy cervical endometrial cancer without application Tachosil® surgery . 2.3 . To evaluate rate type medical intervention clinically symptomatic pelvic lymphoceles analgesic and/or lymphocele puncture drainage . 3 . Study Hypothesis We hypothesize intraoperative application two collagen-fibrin patch ( Tachosil® ) obturator fossa femoral canal reduce number symptomatic pelvic lymphoceles least 66 % ( primary study end point ) . 4 . Study Design Prospective randomize clinical intervention trial 140 woman undergo open laparoscopic pelvic lymphadenectomy cervical endometrial cancer . Randomization computerize randomization list . Women centrally randomize principal investigator ( CT ) . Allocation communicate telephone inform consent obtain lymphadenectomy complete . This single-blinded study , ie patient , surgeon , blind treatment allocation . Outcome assessment perform surgeon , perform lymphadenectomy . Outcome assessor blind treatment allocation . 5 . Treatment All woman undergo open laparoscopic surgery . Within procedure , deem appropriate surgeon , woman undergo pelvic lymphadenectomy . The procedure perform follow : The peritoneum incise parallel iliac vessel . Then , iliac vessel screen presence bulky lymph node . If lymph node debulking perform , patch apply . In woman undergo routine pelvic lymphadenectomy , lymph node tissue remove external iliac vessel , obturator fossa , interiliac region , common iliac region identification appropriate preparation surgical landmark , ie iliac vessel , femoral canal , chorda , obturator nerve . At end procedure , hemostasis check . A Tachosil® patch 4.8x4.8cm attached obturator fossa Tachosil® patch 4.8x4.8cm attached femoral canal side surgery intervention group . In control group , Tachosil® patch use . No specific drainage retroperitoneum perform . All surgical procedure perform study team member Clemens Tempfer , Lukas Hefler , Alexander Reinthaller , experience open laparoscopic pelvic lymph node dissection . In order ensure adequate application Tachosil® patch laparoscopy , surgeon perform least two laparoscopic train operation roll Tachosil® patch around laparoscopic instrument , move 10mm trocar abdomen , flatten . 8 . Statistical analysis A power calculation demonstrate , sample size 70 per group , two-arm study power 80 % detect 66 % absolute difference treatment efficacy significance level 0.05 regard primary outcome parameter , ie symptomatic lymphoceles CTCAE 4.03 grade &gt; 2 . This calculation base publish data Tinelli et al . observe rate 32 % symptomatic lymphoceles placebo group 10 % Tachosil® group ( 5 ) . Assuming 10 % drop out-rate , 140 woman randomize . The chi-square test use comparison frequency cross-tabulations . One Way ANOVA rank use mean . Descriptive statistic ( mean , standard deviation , range ) use demographic data . Bonferroni 's correction use multiple comparison secondary outcome . 10 . Follow-up All woman undergo gynecologic examination transvaginal transabdominal ultrasound examination time discharge hospital , perform physician experienced transvaginal transabdominal ultrasound examination , participate original surgical procedure blind treatment allocation . All woman schedule follow-up visit 4 week surgery include gynecologic examination transvaginal transabdominal ultrasound examination , perform physician experienced transvaginal transabdominal ultrasound examination , participate original surgical procedure blind treatment allocation .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<criteria>Women undergo open laparoscopic surgery cervical endometrial cancer Age 18 70 yr Informed consent Women previously diagnose lymph edema Known disease lymphatic system Immunocompromised woman immunosuppressive medication know disease immune system</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>lymph cyst</keyword>
	<keyword>lymphocele</keyword>
	<keyword>fibrin</keyword>
	<keyword>collagen</keyword>
	<keyword>prevention</keyword>
	<keyword>cancer</keyword>
</DOC>